Meudon, France

Pascale Gueirard

This inventor holds 6 USPTO granted patents and 1 published patent application. Top assignee: Institut Pasteur. Active years: 1999-2008.

USPTO Granted Patents = 6 

% Patents Active = 66.7

Average Co-Inventor Count = 2.0

ph-index = 3

Forward Citations = 16(Granted Patents)


Company Filing History:


Years Active: 1999-2008

Loading Chart...
6 patents (USPTO):Explore Patents

Title: Pascale Gueirard: Innovator in Immunogenic Compositions

Introduction

Pascale Gueirard is a notable inventor based in Meudon, France. He has made significant contributions to the field of immunology, particularly in the development of vaccines. With a total of 6 patents to his name, Gueirard's work has the potential to impact public health positively.

Latest Patents

Gueirard's latest patents include an acellular antibordetella vaccine. This invention relates to an immunogenic composition characterized by the inclusion of an adenyl cyclase-hemolysin (AC-Hly) protein or an immunogenic portion of this AC-Hly. The composition also contains a bacterial extract that includes expression products of the vrg genes from specific strains. Another patent involves an immunogenic composition comprising a bacterial extract containing at least one expression product of the vrg genes. This invention outlines a method for producing the extract, which involves culturing bacteria on blood medium and isolating nonhemolytic colonies.

Career Highlights

Gueirard is affiliated with the prestigious Institut Pasteur, where he conducts his research and development work. His innovative approaches to vaccine development have garnered attention in the scientific community. His contributions are vital in the ongoing efforts to combat infectious diseases.

Collaborations

Gueirard collaborates with Nicole Guiso, a fellow researcher. Their partnership enhances the research output and fosters innovation in their respective fields.

Conclusion

Pascale Gueirard's work in immunogenic compositions showcases his dedication to advancing medical science. His patents reflect a commitment to improving vaccine efficacy and public health.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…